NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
Publication
, Journal Article
Ettinger, DS; Wood, DE; Aggarwal, C; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; D'Amico, TA; Hennon, M ...
Published in: J Natl Compr Canc Netw
December 2019
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances."
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2019
Volume
17
Issue
12
Start / End Page
1464 / 1472
Location
United States
Related Subject Headings
- Practice Guidelines as Topic
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Humans
- Carcinoma, Non-Small-Cell Lung
- Antineoplastic Agents
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Wood, D. E., Aggarwal, C., Aisner, D. L., Akerley, W., Bauman, J. R., … Hughes, M. (2019). NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. J Natl Compr Canc Netw, 17(12), 1464–1472. https://doi.org/10.6004/jnccn.2019.0059
Ettinger, David S., Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, et al. “NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.” J Natl Compr Canc Netw 17, no. 12 (December 2019): 1464–72. https://doi.org/10.6004/jnccn.2019.0059.
Ettinger DS, Wood DE, Aggarwal C, Aisner DL, Akerley W, Bauman JR, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. J Natl Compr Canc Netw. 2019 Dec;17(12):1464–72.
Ettinger, David S., et al. “NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.” J Natl Compr Canc Netw, vol. 17, no. 12, Dec. 2019, pp. 1464–72. Pubmed, doi:10.6004/jnccn.2019.0059.
Ettinger DS, Wood DE, Aggarwal C, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dobelbower M, Gettinger S, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW, Martins RG, Otterson GA, Patel SP, Reckamp KL, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer KW, Yang SC, Gregory K, OCN, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. J Natl Compr Canc Netw. 2019 Dec;17(12):1464–1472.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2019
Volume
17
Issue
12
Start / End Page
1464 / 1472
Location
United States
Related Subject Headings
- Practice Guidelines as Topic
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Humans
- Carcinoma, Non-Small-Cell Lung
- Antineoplastic Agents
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis